Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma

By Lassus Heini   Sihto Harri   Leminen Arto   Joensuu Heikki   Isola Jorma   Nupponen Nina   Butzow Ralf  

Journal of Molecular Medicine, Vol. 84, Iss. 8, 2006-08 ,pp. : 671-681

Springer Publishing Company

Access to resources Recommend Favorite

Application of multiplex ligation-dependent probe amplification, and identification of a heterozygous Alu-associated deletion and a uniparental disomy of chromosome 1 in two patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

By                    

International Journal of Molecular Medicine, Vol. 35, Iss. 6, 2015-01 ,pp. : 1554-1560

Spandidos Publications

Access to resources Recommend Favorite

Large deletions identified in patients with von Willebrand disease using multiple ligation‐dependent probe amplification

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 1083-1086

John Wiley & Sons Inc

Access to resources Recommend Favorite

Frequent Amplification of C-erbB2 (HER-2/Neu) Oncogene in Cervical Carcinoma as Detected by Non-Fluorescence in situ Hybridization Technique on Paraffin Sections

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 83-87

Karger

Access to resources Recommend Favorite

Impact of the 2013 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing of invasive breast carcinoma: a focus on tumours assessed as ‘equivocal’ for HER2 gene amplification by fluorescence in‐situ hybridization

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 880-887

John Wiley & Sons Inc

Access to resources Recommend Favorite